Head and neck cancer recurrence is always a possibility, so it is essential for a patient to remain vigilant for symptoms even after completing an initial round of treatment. This includes seeing a physician for regular checkups as well as any time a potential sign of recurrence develops. Recurrent cancer can form at or near the original site of the tumor (recurrent locoregional cancer) or at distant sites throughout the body (recurrent metastatic cancer). As with all forms of cancer, the outcomes for head and neck cancer recurrences can be significantly improved with early detection and prompt treatment.
The multispecialty team of experts in the Head and Neck Cancer Program at Moffitt Cancer Center generally recommends the same forms of treatment for both newly diagnosed and recurrent head and neck cancers. In either scenario, the goals of treatment are to improve the patient’s prognosis and reduce the discomfort associated with common symptoms and side effects. Depending on the type and location of the head and neck cancer recurrence, an individualized treatment plan may include:
- Radiation therapy
- A multimodal approach that incorporates some or all of the above options
Moffitt is also well known for its groundbreaking clinical trials program, which can provide certain patients with access to promising new therapies that are not yet available through most other health care providers. Many of these trials are specifically designed for participants who are experiencing recurrent head or neck cancer. We always recommend the best possible treatment options for patients, and this may include participation in a clinical trial.
If you’d like to learn more about head and neck cancer recurrence, the experts at Moffitt can help. Call 1-888-663-3488 or complete a new patient registration form online. No referrals are required to make an appointment.